{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ04344",
      "entity_text" : "IFX",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:76720" ]
    }
  },
  "verbose_text" : "Patients who developed ADA showed markedly decreased trough levels of IFX, reduced clinical response, and poor cumulative drug retention rate compared to those who did not developed ADA; these data are comparable with previous reports [XREF_BIBR].",
  "reading_complete" : "2020-08-08T15:34:33Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T15:30:58Z",
  "trigger" : "levels",
  "evidence" : [ "levels of IFX" ],
  "pmc_id" : "5028026",
  "score" : 0
}